N02C1: A phase III randomized, placebo-controlled, double-blind trial of risedronate for prevention of bone loss in premenopausal women undergoing adjuvant chemotherapy for breast cancer (BC)
暂无分享,去创建一个
E. Perez | J. Sloan | C. Loprinzi | M. Carlson | S. Hines | M. Salim | P. Atherton | B. Mincey | E. Chottiner | S. Thomas